pI: 9.8518 |
Length (AA): 355 |
MW (Da): 36831 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
3 | 249 | 4xwu (A) | 57 | 494 | 26.00 | 0.013 | 1 | 0.950275 | -0.27 |
3 | 354 | 5gvh (A) | 3 | 312 | 38.00 | 0 | 1 | 1.27225 | 0.32 |
3 | 348 | 2gjl (A) | 4 | 318 | 35.00 | 0 | 1 | 1.24135 | 0.06 |
4 | 354 | 5gvj (A) | 4 | 312 | 40.00 | 0.00052 | 1 | 1.22553 | 0.43 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Dormant phase. | hasan |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Dormant phase. | murphy |
hasan | Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. |
murphy | Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. |
Ortholog group members (OG5_129399)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G64250 | Aldolase-type TIM barrel family protein |
Candida albicans | CaO19.7204 | potential fungal 2-nitropropane dioxygenase similar to S. cerevisiae YJR149W |
Candida albicans | CaO19_7204 | hypothetical protein |
Dictyostelium discoideum | DDB_G0275593 | hypothetical protein |
Leishmania braziliensis | LbrM.20.0540 | enoyl-[acyl-carrier-protein] reductase, putative |
Leishmania braziliensis | LbrM.21.1500 | 2-nitropropane dioxygenase, putative |
Leishmania donovani | LdBPK_340630.1 | enoyl-[acyl-carrier-protein] reductase, putative |
Leishmania infantum | LinJ.34.0630 | enoyl-[acyl-carrier-protein] reductase, putative |
Leishmania major | LmjF.34.0610 | enoyl-[acyl-carrier-protein] reductase, putative |
Leishmania mexicana | LmxM.33.0610 | enoyl-[acyl-carrier-protein] reductase, putative |
Mycobacterium tuberculosis | Rv2781c | Possible alanine rich oxidoreductase |
Mycobacterium tuberculosis | Rv3553 | Possible oxidoreductase |
Mycobacterium ulcerans | MUL_4116 | 2-nitropropane dioxygenase |
Mycobacterium ulcerans | MUL_2153 | hypothetical protein |
Oryza sativa | 4345877 | Os08g0485400 |
Saccharomyces cerevisiae | YJR149W | hypothetical protein |
Trichomonas vaginalis | TVAG_479680 | 2-nitropropane dioxygenase precursor, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0753 | trans-2-enoyl-ACP reductase, FabK |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu2828 | Mycobacterium tuberculosis | non-essential | nmpdr |
mtu3614 this record | Mycobacterium tuberculosis | non-essential | nmpdr |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.1
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Streptococcus pneumoniae | Enoyl-(Acyl-carrier-protein) reductase | Compounds | References |